Logo Logo
Switch Language to German
Bohnenberger, Hanibal; Kaderali, Lars; Stroebel, Philipp; Yepes, Diego; Plessmann, Uwe; Dharia, Neekesh V.; Yao, Sha; Heydt, Carina; Merkelbach-Bruse, Sabine; Emmert, Alexander; Hoffmann, Jonatan; Bodemeyer, Julius; Reuter-Jessen, Kirsten; Lois, Anna-Maria; Dröge, Leif Hendrik; Baumeister, Philipp; Walz, Christoph; Biggemann, Lorenz; Walter, Roland; Häupl, Björn; Comoglio, Federico; Pan, Kuan-Ting; Scheich, Sebastian; Lenz, Christof; Kueffer, Stefan; Bremmer, Felix; Kitz, Julia; Sitte, Maren; Beissbarth, Tim; Hinterthaner, Marc; Sebastian, Martin; Lotz, Joachim; Schildhaus, Hans-Ulrich; Wolff, Hendrik; Danner, Bernhard C.; Brandts, Christian; Büttner, Reinhard; Canis, Martin; Stegmaier, Kimberly; Serve, Hubert; Urlaub, Henning; Oellerich, Thomas (2018): Comparative proteomics reveals a diagnostic signature for pulmonary head‐and‐neck cancer metastasis. In: EMBO Molecular Medicine, Vol. 10, No. 9, e8428
Creative Commons Attribution 1MB


Patients with head-and-neck cancer can develop both lung metastasis and primary lung cancer during the course of their disease. Despite the clinical importance of discrimination, reliable diagnostic biomarkers are still lacking. Here, we have characterised a cohort of squamous cell lung (SQCLC) and head-and-neck (HNSCC) carcinomas by quantitative proteomics. In a training cohort, we quantified 4,957 proteins in 44 SQCLC and 30 HNSCC tumours. A total of 518 proteins were found to be differentially expressed between SQCLC and HNSCC, and some of these were identified as genetic dependencies in either of the two tumour types. Using supervised machine learning, we inferred a proteomic signature for the classification of squamous cell carcinomas as either SQCLCor HNSCC, with diagnostic accuracies of 90.5% and 86.8% in cross- and independent validations, respectively. Furthermore, application of this signature to a cohort of pulmonary squamous cell carcinomas of unknown origin leads to a significant prognosticseparation. This study not only provides a diagnostic proteomicsignature for classification of secondary lung tumours in HNSCC patients, but also represents a proteomic resource for HNSCC andSQCLC.